Heavyweight 2016 Chronic Disease Internet+ Forum Announces Prospectus

On December 1, 2015, the National Health and Family Planning Commission issued the "Notice on Doing a Good Job in the Pilot Work of Tiered Diagnosis and Treatment for Hypertension and Diabetes," which clarified the key tasks of tiered diagnosis and treatment for hypertension and diabetes, and outlined a service flowchart for the tiered diagnosis and treatment work.

In accordance with the requirements of the National Health and Family Planning Commission, key tasks for the tiered diagnosis and treatment of hypertension and diabetes include establishing health records for patients under this tiered system, clarifying the functional roles of medical institutions at different levels, implementing a team-based contracted service model, and defining standard service processes for the tiered management of hypertension and diabetes.

To better integrate hospitals, physicians, patients, the government, medical insurance providers, and commercial insurers through “Internet+” initiatives in the field of chronic disease management, thereby forming a synergistic force and ultimately achieving data-driven decision-making and services for chronic disease management.

2016 Internet+ Chronic Disease Forum will bring together elites from medical societies, primary care hospitals, experts, mobile health companies, pharmaceutical firms, insurance companies, and investors to discuss Internet+ solutions for chronic diseases. While fostering intellectual exchange among these stakeholders, the conference will focus on in-depth analysis of hot topics such as data connectivity and integration in chronic disease management, ecosystem building and business model exploration for the Internet-based chronic disease industry chain, and tiered diagnosis and treatment.

Tong Weidong, founder of Tangyi, stated that the internet is merely a medium, while healthcare remains the core. He believes that chronic disease management can only achieve optimal efficiency by truly penetrating to the grassroots level. In this process, it is essential to converge forces from all sectors to strengthen primary care and safeguard health, thereby balancing the interests and demands of all stakeholders. Only then can tiered diagnosis and treatment for chronic diseases be realized.

Cen Minghua, founder of Chengyi, stated that chronic disease management currently faces three challenges: insufficient health management awareness among patients, limited energy and resources available to physicians, and a lack of effective tools for chronic disease management. In the era of "Internet Plus," chronic disease management should be patient-experience-centric, enhancing patients' self-management awareness. It should establish physician teams comprising doctors from tertiary hospitals, county-level hospitals, and community health centers as the primary service providers, empowering physicians to become operators and promoters of chronic disease management. Meanwhile, mobile healthcare service applications should be leveraged to provide comprehensive, effective, and convenient support for both physicians and patients. As the healthcare payment system continues to improve, patient experience will steadily enhance.

Zhang Zuo, CEO of Yi Liu Zhu Shou (Oncology Assistant), stated: “Whether it is chronic disease management or tiered diagnosis and treatment, the challenge lies in bridging gaps across time and space. The defining characteristics of the internet are connectivity and information aggregation. In response to the trend of integrating healthcare with the internet, Yi Liu Zhu Shou has entered the oncology care ecosystem by focusing on the intra-diagnostic phase. Building upon a physician team-based patient management system, we continue to expand into scenarios such as doctor-patient communication, patient education, hospitalization scheduling, and follow-up guidance, actively exploring solutions to enhance the efficiency of oncology medical services.”

Niu Xiaoqiang, founder of Qingwutong Gene, believes that the latest advances in precision medicine technology can help improve chronic disease management models and address many previously intractable problems. These technologies will play a key role in early detection, blocking pathogenic pathways (disease-causing genes), adjunctive pharmacotherapy, subphenotyping of diseases, and disease progression monitoring (proteomics). In the future, they will also provide greater opportunities for drug development and gene therapy. Furthermore, if large-scale genetic screening is conducted among populations susceptible to chronic diseases and integrated with primary care within the tiered diagnosis and treatment system, a new model for chronic disease prevention and treatment will emerge. This approach would significantly enhance the effectiveness of tiered diagnosis and treatment, potentially curbing the rising prevalence of chronic diseases and addressing major issues concerning public welfare and national health.

This forum was initiated and hosted by the “Diabetes Education and Management Branch of the China Medical Promotion Association,” co-organized by “VCBeat,” undertaken by Tang Yisheng, Cheng Yisheng, and Yi Liu Zhushou, with media support from “China County Health.”

Time: February 23, 2016, 9:00-17:00

Location: Beijing (to be notified upon successful registration)

Scale: 200–300 attendees (first come, first served)

Registration: Please scan the QR code below the article to register, or visit directlyhttp://form.mikecrm.com/f.php?t=015YV7 Registration required; limited seating. No walk-ins accepted.

Conference Agenda (Tentative; subject to change based on the final announcement)



Partial Guest Profiles (Proposed Invitees, Listed in No Particular Order)）：

Zhang Lixin
President of the Sub-health Professional Committee, Chinese Medical Promotion Association; President of the Diabetes Education and Management Branch; Deputy Director of the Training Center, China Academy of Chinese Medical Sciences

Pu Liang
Secretary-General of the Diabetes Education and Management Branch of the Chinese Medical Promotion Association, Editor-in-Chief of Health Home Magazine

Hu Dayi
Distinguished Expert with Outstanding Contributions in Beijing, Recipient of the State Council Special Government Allowance for Experts. Renowned expert in cardiovascular diseases and medical educator. Director of the Institute of Cardiovascular Diseases at Capital Medical University; Director of the Heart Research Institute and Chief of the Department of Cardiology at Peking University People’s Hospital; Director of the Center for Diagnosis and Treatment of Cardiovascular Diseases at Beijing Tongren Hospital. Chairman of the Chinese Society of Cardiology under the Chinese Medical Association; Chairman of the Beijing Society of Cardiology under the Chinese Medical Association; Chairman of the Evidence-Based Medicine Professional Committee under the Chinese Medical Doctor Association; Chairman of the Cardiac Pacing and Electrophysiology Branch under the Chinese Society of Biomedical Engineering. Member of numerous prestigious academic societies both domestically and internationally. Editor-in-Chief of *Chinese Journal of Pharmaceutical Guidance*; Associate Editor and Editorial Board Member for various domestic and international journals, including *Chinese Journal of Cardiac Arrhythmias* and *Chinese Journal of Interventional Cardiology*.

Xiang Hongding
Professor, Chief Physician, and Doctoral Supervisor at Peking Union Medical College Hospital
Director of the Diabetes Center, Peking Union Medical College Hospital
President of the Chinese Diabetes Society
Chairman, Diabetes Professional Committee, Chinese Association of Geriatric Health Care
Chief Health Education Expert of the Central Office for Building Spiritual Civilization and the National Health and Family Planning Commission
Deputy Editor-in-Chief of Chinese Journal of Diabetes
Gu Xuefei
National Health and Family Planning Commission, Health Development Research Center, Associate Researcher, Doctoral Candidate, Deputy Director of the Medical Security Research Office

Xu Qian
Deputy General Manager, Investment Headquarters, Fosun Pharma

Wen Xiaoling
General Manager, Tianjin Tasly E-Commerce Co., Ltd.

Li Datao
Founder of VCBeat

Wang Yan'an
Executive Editor-in-Chief, China County-Level Health

Chen Yunhan
Partner, Huarui Investment

Wang Jun
Partner at Puhua Capital

Jiang Ping
Chairman of Lude Capital, Partner at CICC Capital

Dr.2
Chairman of Zhenlipai

Tong Weidong
Founder of Tang Doctor

Xu Feng
Co-Founder of Tang Doctor

Cen Minghua
Founder of Orange Doctor

Ma Ji
Co-founder of Orange Doctor

Peng Zhigang
Chairman of Yi Liu Assistant

Zhang Zuo
CEO of MedTumor Assistant

Niu Xiaoqiang
Founder of Qingwutong Gene